NCT03775655View on ClinicalTrials.gov

Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

January 10, 2019

Study Completion Date

January 10, 2019

Conditions
Cesarean SectionSpinal AnesthesiaDexmedetomidine
Interventions
DRUG

Dexmedetomidine

10μg dexmedetomidine will be added to the injectate to be injected intrathecally

Trial Locations (1)

Unknown

Menoufia University Hospitals, Shibīn al Kawm

All Listed Sponsors
lead

Menoufia University

OTHER

NCT03775655 - Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section | Biotech Hunter | Biotech Hunter